Improving cancer treatment by understanding tumor biology
Making cancer precision medicine real: bottlenecks and opportunities
This study is working on improving cancer treatments by finding better ways to analyze RNA, which can help predict how well different drugs will work for patients, and it aims to create models that show how tumors react to treatments, making personalized care available to more people with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10924054 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer precision medicine by addressing the scientific challenges that limit its effectiveness for most patients. It aims to develop new methods for analyzing RNA-based diagnostics, which are more predictive of drug responses than traditional DNA tests. The project will also create comprehensive models to predict how tumors respond to various treatments, taking into account the tumor microenvironment and the interactions between tumor and immune cells. By expanding the types of cell models used and improving drug action assessments, the research seeks to make personalized cancer treatments accessible to a broader patient population.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients whose tumors have not responded to standard treatments or those seeking personalized therapy options.
Not a fit: Patients with non-cancerous conditions or those whose tumors are already effectively managed by existing therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments for a larger number of patients.
How similar studies have performed: Previous research has shown promise in using RNA-based diagnostics and advanced modeling techniques to improve cancer treatment outcomes, indicating that this approach has potential for success.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Golub, Todd R. — Broad Institute, INC.
- Study coordinator: Golub, Todd R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.